amiodarone has been researched along with Syndrome in 25 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 52-year-old woman developed symmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of amiodarone treatment." | 7.67 | Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy. ( Abarbanel, JM; Frisher, S; Herishanu, Y; Osiman, A, 1987) |
| "A patient with the familial syndrome of Q-T prolongation, ventricular arrhythmias, and syncope was effectively treated with amiodarone." | 7.66 | Effective management of the long q-t syndrome with amiodarone. ( Bashour, T; Cheng, TO; Jokhadar, M, 1981) |
| "Amiodarone induces in patients "low T3-syndrome" characterized by normal T4." | 7.66 | [Amiodarone-induce "low T3-syndrome" (author's transl)]. ( Beckers, C; Jonckheer, MH; Smekens, L, 1978) |
| "Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone." | 7.66 | Use of amiodarone in bradycardia-tachycardia syndrome. ( Brown, AK; Newton, P; Primhak, RA, 1978) |
| "Amiodarone is an effective antiarrhythmic that has been used in Europe for over a decade and has been available for investigational use in North America for a shorter time." | 5.27 | Diffuse alveolar damage syndrome associated with amiodarone therapy. ( Henning, H; Huckell, VF; Jirik, FR; Ostrow, DV, 1983) |
| "A 52-year-old woman developed symmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of amiodarone treatment." | 3.67 | Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy. ( Abarbanel, JM; Frisher, S; Herishanu, Y; Osiman, A, 1987) |
| "A patient with the familial syndrome of Q-T prolongation, ventricular arrhythmias, and syncope was effectively treated with amiodarone." | 3.66 | Effective management of the long q-t syndrome with amiodarone. ( Bashour, T; Cheng, TO; Jokhadar, M, 1981) |
| "Amiodarone induces in patients "low T3-syndrome" characterized by normal T4." | 3.66 | [Amiodarone-induce "low T3-syndrome" (author's transl)]. ( Beckers, C; Jonckheer, MH; Smekens, L, 1978) |
| "Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone." | 3.66 | Use of amiodarone in bradycardia-tachycardia syndrome. ( Brown, AK; Newton, P; Primhak, RA, 1978) |
| "The most important arrhythmia is ventricular tachycardia which degenerates to ventricular fibrillation." | 2.43 | [Strategy for cardiac arrhythmias in acute coronary syndrome]. ( Sugi, K, 2006) |
| "The short QT syndrome has been recently recognised as a genetic ion channel dysfunction." | 2.43 | Short QT syndrome: a case report and review of literature. ( Cao, Q; Lu, LX; Yu, K; Zhang, X; Zhou, W; Zhu, C, 2006) |
| "Right bundle branch block, persistent ST segment elevation in right precordial leads and sudden cardiac death, unexplainable by currently known disease, define a new distinct clinical and electrocardiographic syndrome." | 2.39 | Right bundle branch block, persistent ST-segment elevation in V1-V3 and sudden cardiac death: always a distinct syndrome? ( Boccalatte, A; Cuomo, S; D'Onofrio, A; Musto, B, 1995) |
| "Amiodarone (200 mg/day) was administered for 6 months and programmed ventricular stimulation was repeated." | 1.32 | Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient. ( Kanmatsuse, K; Kasamaki, Y; Kofune, T; Masaki, R; Ohkubo, K; Okumura, Y; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, I; Yamada, T, 2003) |
| "It is stated that CHD patients with arrhythmia develop latent hypothyrosis of T3-low-syndrome type." | 1.29 | [The effect of kordaron on thyroid function in patients with ischemic heart disease]. ( Tereshchenko, IV; Tsepelev, VV, 1995) |
| "Amiodarone is an effective antiarrhythmic that has been used in Europe for over a decade and has been available for investigational use in North America for a shorter time." | 1.27 | Diffuse alveolar damage syndrome associated with amiodarone therapy. ( Henning, H; Huckell, VF; Jirik, FR; Ostrow, DV, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wasserstrum, Y | 1 |
| Raanani, P | 1 |
| Kornowski, R | 1 |
| Iakobishvili, Z | 1 |
| Jolly, U | 1 |
| Klein, G | 1 |
| Mattos, JP | 1 |
| Nicaretta, DH | 1 |
| Rosso, AL | 1 |
| Kirkali, Z | 1 |
| Ohkubo, K | 1 |
| Watanabe, I | 1 |
| Okumura, Y | 1 |
| Yamada, T | 1 |
| Masaki, R | 1 |
| Kofune, T | 1 |
| Oshikawa, N | 1 |
| Kasamaki, Y | 1 |
| Saito, S | 1 |
| Ozawa, Y | 1 |
| Kanmatsuse, K | 1 |
| Arxer, A | 1 |
| Novoa, L | 1 |
| Vieito Amor, M | 1 |
| Hernández Iniesta, J | 1 |
| Villalonga, A | 1 |
| Kharash, LM | 1 |
| Chenzbraun, AI | 1 |
| Sugi, K | 1 |
| Lu, LX | 1 |
| Zhou, W | 1 |
| Zhang, X | 1 |
| Cao, Q | 1 |
| Yu, K | 1 |
| Zhu, C | 1 |
| Paul, G | 1 |
| Yusuf, S | 1 |
| Sharma, S | 1 |
| Jirik, FR | 1 |
| Henning, H | 1 |
| Huckell, VF | 1 |
| Ostrow, DV | 1 |
| Conte, MR | 1 |
| Gaita, F | 1 |
| Asteggiano, R | 1 |
| Bocchiardo, M | 1 |
| Rosettani, E | 1 |
| Riccioni, N | 1 |
| Bartolomei, C | 1 |
| Bashour, T | 1 |
| Jokhadar, M | 1 |
| Cheng, TO | 1 |
| Tereshchenko, IV | 1 |
| Tsepelev, VV | 1 |
| Proclemer, A | 1 |
| Facchin, D | 1 |
| Feruglio, GA | 1 |
| Nucifora, R | 1 |
| D'Onofrio, A | 1 |
| Cuomo, S | 1 |
| Musto, B | 1 |
| Boccalatte, A | 1 |
| Bariciak, MD | 1 |
| Nichols, BD | 1 |
| Rogers, KC | 1 |
| Wolfe, DA | 1 |
| Bennett, DH | 1 |
| Gribbin, B | 1 |
| Birkhead, JS | 1 |
| Jonckheer, MH | 1 |
| Smekens, L | 1 |
| Beckers, C | 1 |
| Barbosa Lopes, AA | 1 |
| Scalabrini Neto, A | 1 |
| Barbosa, SA | 1 |
| Tranchesi, J | 1 |
| Brown, AK | 1 |
| Primhak, RA | 1 |
| Newton, P | 1 |
| Abarbanel, JM | 1 |
| Osiman, A | 1 |
| Frisher, S | 1 |
| Herishanu, Y | 1 |
| Martos, JA | 1 |
| Conget, JI | 1 |
| Abad, C | 1 |
4 reviews available for amiodarone and Syndrome
| Article | Year |
|---|---|
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Elect | 2006 |
Short QT syndrome: a case report and review of literature.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; ERG1 Pota | 2006 |
Right bundle branch block, persistent ST-segment elevation in V1-V3 and sudden cardiac death: always a distinct syndrome?
Topics: Adult; Amiodarone; Bundle-Branch Block; Death, Sudden, Cardiac; Echocardiography; Electrocardiograph | 1995 |
Cataracts in systemic diseases and syndromes.
Topics: Amiodarone; Cataract; Cataract Extraction; Diabetes Complications; Diabetic Retinopathy; Female; Hum | 1995 |
1 trial available for amiodarone and Syndrome
| Article | Year |
|---|---|
Treatment of the bradycardia-tachycardia syndrome with low doses of amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Clinical Trials as Topic; Female; Humans; Male; Middle A | 1981 |
20 other studies available for amiodarone and Syndrome
| Article | Year |
|---|---|
Concomitant Treatment with Ibrutinib and Amiodarone Causing Reversible Heart Failure Syndrome.
Topics: Adenine; Aged; Amiodarone; Atrial Fibrillation; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions | 2016 |
Blue man syndrome.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Pigmentation Disorders; Syndrome; Tachycardi | 2016 |
Progressive supranuclear palsy-like syndrome induced by amiodarone and flunarizine.
Topics: Aged; Amiodarone; Female; Flunarizine; Humans; Supranuclear Palsy, Progressive; Syndrome; Vasodilato | 2009 |
Re: The patient with chronic epididymitis: characterization of an enigmatic syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Dose-Response Relationship, Drug; Epididymitis; | 2002 |
Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Electrocardiogr | 2003 |
[Bradycardia-tachycardia syndrome during spinal anesthesia].
Topics: Aged; Amiodarone; Anesthesia, Spinal; Aneurysm; Anti-Arrhythmia Agents; Anticoagulants; Bradycardia; | 2003 |
[Pacemaker syndrome in the absence of artificial pacemaker (pseudopacemaker syndrome)].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Diagnosis, Differential; Echocar | 2004 |
Unmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; | 2006 |
Diffuse alveolar damage syndrome associated with amiodarone therapy.
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Benzofurans; Humans; Lung; Lung Diseases; Male; Pulmonary | 1983 |
[Amiodarone in the bradycardia-tachycardia syndrome. 2-year follow-up].
Topics: Adult; Aged; Amiodarone; Benzofurans; Bradycardia; Female; Follow-Up Studies; Humans; Male; Middle A | 1982 |
Effective management of the long q-t syndrome with amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Heart Ventricles; Hu | 1981 |
[The effect of kordaron on thyroid function in patients with ischemic heart disease].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Male; Middle Aged; Myocardia | 1995 |
[Recurrent ventricular fibrillation, right bundle-branch block and persistent ST segment elevation in V1-V3: a new arrhythmia syndrome? A clinical case report].
Topics: Aged; Amiodarone; Bundle-Branch Block; Combined Modality Therapy; Death, Sudden, Cardiac; Defibrilla | 1993 |
Amiodarone-induced blue-gray syndrome.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Photosensitivity Disorders; Skin Pigmentatio | 2000 |
Identical twins with differing forms of ventricular pre-excitation.
Topics: Amiodarone; Child; Diseases in Twins; Electrocardiography; Female; Heart; Heart Conduction System; H | 1978 |
[Amiodarone-induce "low T3-syndrome" (author's transl)].
Topics: Amiodarone; Benzofurans; Heart Diseases; Humans; Syndrome; Triiodothyronine | 1978 |
[Wolff-Parkinson-White syndrome associated with morphology of complete left bundle branch block in a person with patent ductus arteriosus].
Topics: Amiodarone; Bundle of His; Bundle-Branch Block; Ductus Arteriosus, Patent; Electrocardiography; Hear | 1978 |
Use of amiodarone in bradycardia-tachycardia syndrome.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Corneal Diseases; Female; Humans; Male; Middle Aged; Syn | 1978 |
Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy.
Topics: Amiodarone; Biopsy; Cardiac Complexes, Premature; Cerebellar Diseases; Female; Humans; Middle Aged; | 1987 |
[Long-lasting febrile syndrome as a manifestation of hyperthyroidism caused by amiodarone].
Topics: Amiodarone; Fever; Heart Valve Prosthesis; Humans; Hyperthyroidism; Male; Middle Aged; Syndrome | 1988 |